Photon Biosciences, LLC
Photon Biosciences, LLC
  • HOME
  • Technology
  • About Us
    • Team
    • Careers
    • Investors & Partners
    • Contact Us
    • News
  • Resources
    • Testimonials
    • Documents
  • COVID-19 Response
  • COVID-19 Antibodies
  • More
    • HOME
    • Technology
    • About Us
      • Team
      • Careers
      • Investors & Partners
      • Contact Us
      • News
    • Resources
      • Testimonials
      • Documents
    • COVID-19 Response
    • COVID-19 Antibodies

  • HOME
  • Technology
  • About Us
  • Resources
  • COVID-19 Response
  • COVID-19 Antibodies

PBS® Technology

Enhancement of Imaging

Enhancement of Imaging

Labelled Antibodies and stably expressing cell lines

Enhancement of Imaging

Enhancement of Imaging

Enhancement of Imaging

  Imaging

Enhancement solutions & media

Biomedical Imaging

Enhancement of Imaging

Biomedical Imaging

  

IR Upconversion probes

PBS® Technology

Our core technology is a new ultrasensitive detection platform that combines bioengineered proteins with a unique in vivo biomineralization process that results in a number of different genetically expressible luminescent bionanoparticles that are non-bleaching and non-blinking with luminescence intensities that rivals and surpasses many fluorescent organic molecules. The excitation and emission wavelengths of these expressible bionanoparticles can be tuned with the composition of the mineralization process and span much of the visible and near infrared regions of the electromagnetic spectrum.  Because of its unique photophysical properties, PBS® has been developed into new ultrasensitive probes for biomolecular research, detection technologies, and cellular imaging.

Unlimited Source of Photons from a Single Bionanoparticle

Photon Biosciences, LLC was founded in 2017 to develop and market entirely new classes of genetically expressible phosphorescent proteins that never photobleach and have luminocities that rival GFP.


Originally formed as a Washington State University start-up, Photon Biosciences, LLC has received Phase I funding from the National Institutes of Health SBIR program (NIGMS SBIR) and a GAP grant from the Washington Research Foundation to develop our core technologies and commercialize a variety of product lines for the biomedical research community and biotechnology.

Core Technology:

  • Non-Photobleaching
  • Non-Photoblinking
  • Bright
  • Expressible in Live Cells
  • Non-Toxic
  • Narrow Luminescent Bands
  • Upconversion Capable
  • Phosphorescent

  • Reactive Bionanoparticles for Protein Labeling
  • Fusion Proteins
  • Two-Photon Probes
  • Plasmids for Celluar Based Imaging / Detection
  • Custom ELISA Kits

Our Distribution Partners

Investors & Partners

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Photon Biosciences, LLC

2205 North Woodruff Rd, Suite # 2, Spokane Valley, Washington, 99206, United States

(509) 418 2842

Copyright © 2021 Photon Biosciences, LLC - All Rights Reserved.

  • News

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept